Release Date: 31/10/14 09:17 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 1.36MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%